COMBINATORX

Pharmaceuticals, in particular, combination therapeutic compositions in the nature of antiproliferatives for the treatment of hyperproliferative diseases, anticancertherapeutics for the treatment of cancer, neuroprotectants for the treatment of neurodegenerative diseases, and anti-infectives for the treatment of infectious diseases